FDA Approved: FENSOLVI — Supplemental Application (TOLMAR Inc.)

View source ↗

Summary

FDA approved a supplemental application for FENSOLVI (leuprolide acetate) filed by Tolmar Inc. This action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• FENSOLVI (Leuprolide acetate)

Snippet

SUPPL AP for FENSOLVI (LEUPROLIDE ACETATE)